-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JuaD91S6a4FXiQqzu00Xy97itapv9wyTFfQKrTf5VG+bwS4h7hCGR802x1RfEMrF JQBnB/wTxenRCjXSdj6CaA== 0000893838-06-000054.txt : 20060503 0000893838-06-000054.hdr.sgml : 20060503 20060503210647 ACCESSION NUMBER: 0000893838-06-000054 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050912 FILED AS OF DATE: 20060503 DATE AS OF CHANGE: 20060503 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REXAHN PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001228627 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113516358 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9620 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 2402685300 MAIL ADDRESS: STREET 1: 9620 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: CORPORATE ROAD SHOW DOT COM INC DATE OF NAME CHANGE: 20030423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McIntosh David M CENTRAL INDEX KEY: 0001317248 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50590 FILM NUMBER: 06805779 BUSINESS ADDRESS: BUSINESS PHONE: (240) 268-5300 MAIL ADDRESS: STREET 1: 9620 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 rexform4mcintosh_ex.xml X0202 4 2005-09-12 0 0001228627 REXAHN PHARMACEUTICALS, INC. RXHN 0001317248 McIntosh David M 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 1 0 0 0 Stock option (right to buy) 0.24 2005-12-08 4 D 0 125000 D 2014-04-20 Common stock 125000 0 D Stock option (right to buy) 0.80 2005-12-08 4 A 0 125000 A 2014-04-20 Common stock 125000 125000 D Stock option (right to buy) 3.00 2005-09-12 4 A 0 20000 0 A 2006-09-12 2015-09-12 Common stock 20000 20000 D Stock option (right to buy) 1.20 2006-05-01 4 A 0 20000 0 A 2007-05-01 2016-05-01 Common stock 20000 20000 D The options vest and become exercisable as to 30% of the options on April 20, 2005; another 30% of the options on April 20, 2006; and the remaining 40% of the options on April 20, 2007. The transaction involved an amendment of outstanding options to change the exercise price with respect to 125,000 options from $0.24 to $0.80, resulting in the deemed cancellation of the original options and the grant of replacement options with the same vesting and exercisability terms as the cancelled options. /s/ Ted T.H. Jeong as attorney-in-fact for David M. McIntosh 2006-05-03 -----END PRIVACY-ENHANCED MESSAGE-----